We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+24.54%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$8.03B
AUM Growth
+$752M
Cap. Flow
-$754M
Cap. Flow %
-9.4%
Top 10 Hldgs %
69.33%
Holding
70
New
6
Increased
6
Reduced
13
Closed
16

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$476M
2
ALGN icon
Align Technology
ALGN
+$197M
3
VIE
Viela Bio, Inc. Common Stock
VIE
+$116M
4
UBER icon
Uber
UBER
+$94.2M
5
KYNB
Kyntra Bio
KYNB
+$18.5M

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$258M
2
SE icon
Sea Limited
SE
+$258M
3
META icon
Meta Platforms (Facebook)
META
+$228M
4
JD icon
JD.com
JD
+$136M
5
TAL icon
TAL Education Group
TAL
+$119M

Sector Composition

Rank Sector Weight
1 Healthcare 34.79%
2 Consumer Discretionary 17.89%
3 Communication Services 16.91%
4 Technology 11.84%
5 Consumer Staples 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLCO icon
26
Melco Resorts & Entertainment
MLCO
$2.2B
$53.1M 0.66%
2,197,850
-2,197,850
-50% -$47.8M
NFLX icon
27
Netflix
NFLX
$306B
$44.1M 0.55%
1,364,000
-1,246,020
-48% -$36.9M
BEDU
28
DELISTED
Bright Scholar Education Holdings
BEDU
$35.2M 0.44%
996,449
ARVN icon
29
Arvinas
ARVN
$531M
$35.1M 0.44%
855,308
GMAB icon
30
Genmab
GMAB
$17.5B
$33.5M 0.42%
1,500,000
ZLAB icon
31
Zai Lab
ZLAB
$2.06B
$33.2M 0.41%
798,001
SDC
32
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$25.3M 0.32%
2,898,086
-25,000
-0.9% -$250K
GTHX
33
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$25.1M 0.31%
949,431
MOGU
34
MOGU Inc
MOGU
$16.4M
$23.8M 0.3%
870,581
KNSA icon
35
Kiniksa Pharmaceuticals
KNSA
$6.23B
$21M 0.26%
1,895,888
+28,266
+2% +$246K
AKRO
36
DELISTED
Akero Therapeutics
AKRO
$19.8M 0.25%
891,201
+141,777
+19% +$2.93M
RGNX icon
37
Regenxbio
RGNX
$619M
$18.7M 0.23%
456,000
QCOM icon
38
Qualcomm
QCOM
$165B
$17.6M 0.22%
+200,000
New +$16.7M
UXIN
39
Uxin Ltd
UXIN
$308M
$16.4M 0.2%
72,443
-21,949
-23% -$5.93M
IGMS
40
DELISTED
IGM Biosciences
IGMS
$13.4M 0.17%
350,000
HOOK
41
DELISTED
HOOKIPA Pharma
HOOK
$11.5M 0.14%
94,325
EIDX
42
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$10.3M 0.13%
178,600
SOHU
43
Sohu.com
SOHU
$353M
$8.97M 0.11%
802,034
RDGT
44
Ridgetech Inc
RDGT
$696K
$8.81M 0.11%
134
MRUS
45
DELISTED
Merus
MRUS
$8.45M 0.11%
+600,000
New +$9.65M
ARGX icon
46
argenx
ARGX
$55.2B
$8.03M 0.1%
+50,000
New +$6.76M
RCUS icon
47
Arcus Biosciences
RCUS
$3.33B
$7.75M 0.1%
767,128
AMG icon
48
Affiliated Managers Group
AMG
$9.53B
$6.05M 0.08%
+71,345
New +$5.85M
TXG icon
49
10x Genomics
TXG
$5.88B
$5.72M 0.07%
75,000
TCRR
50
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$4.61M 0.06%
322,903

Similar funds

HHLR Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, HHLR Advisors held 70 positions worth $8.03B, up 10% from $7.27B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HHLR Advisors withdrew a net $754M in Q4 2019, closing 16 positions and reducing 13 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, HHLR Advisors opened a new position in Zoom worth $471M.

  • HHLR Advisors's largest Q4 2019 buy was Zoom: 6,916,078 shares worth $471M.
  • HHLR Advisors added most to Align Technology in Q4 2019, an estimated $197M increase.
  • HHLR Advisors's biggest Q4 2019 reduction was New Oriental, cutting an estimated $258M.
  • HHLR Advisors fully exited Meta Platforms (Facebook) in Q4 2019, selling an estimated $228M.
  • HHLR Advisors's ten largest holdings make up 69% of its $8.03B portfolio in Q4 2019.
  • HHLR Advisors opened 6 new positions and closed 16 in Q4 2019.
  • HHLR Advisors's portfolio value rose 10% quarter-over-quarter to $8.03B.

Based on HHLR Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.